FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115944392> ?p ?o ?g. }

• W2115944392 abstract "Advanced glycation end products (AGEs) and receptor RAGE interaction contribute to endothelial cell damage in diabetes. Several thrombogenic abnormalities are also involved in diabetic vascular complications. However, the pathological role of thrombin and protease-activated receptor-1 (PAR-1) system in AGE-induced endothelial cell (EC) damage remains unclear. In this study, we investigated the effects of rivaroxaban, an inhibitor of factor Xa on 3% citrated human plasma-evoked reactive oxygen species (ROS) generation and RAGE, monocyte chemoattractant protein-1 (MCP-1) and intercellular adhesion molecule-1 (ICAM-1) gene expression in AGE-exposed ECs. We further examined whether FR171113, an inhibitor of PAR-1 blocked the plasma-induced EC damage and if AGEs increased PAR-1 expression in ECs. Human citrated plasma stimulated ROS generation and RAGE, MCP-1 and ICAM-1 expression in ECs, all of which were potentiated by the treatment with AGEs. Rivaroxaban or FR171113 significantly inhibited these derangements in plasma- or plasma plus AGE-exposed ECs. Moreover, AGEs significantly increased the PAR-1 levels in ECs. The present study suggests that citrated plasma could induce oxidative and inflammatory reactions in ECs via the activation of thrombin-PAR-1 system and that AGEs could potentiate the plasma-evoked EC damages via up-regulation of PAR-1. Blockade of the crosstalk between AGE-RAGE axis and coagulation system by rivaroxaban might be a novel therapeutic target for thromboembolic disorders in diabetes." @default.
• W2115944392 created "2016-06-24" @default.
• W2115944392 creator A5017854204 @default.
• W2115944392 creator A5029975728 @default.
• W2115944392 creator A5030113532 @default.
• W2115944392 creator A5042961127 @default.
• W2115944392 creator A5086054133 @default.
• W2115944392 date "2014-03-13" @default.
• W2115944392 modified "2023-10-05" @default.
• W2115944392 title "Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression" @default.
• W2115944392 cites W1547165466 @default.
• W2115944392 cites W1580322195 @default.
• W2115944392 cites W1603429979 @default.
• W2115944392 cites W1665357608 @default.
• W2115944392 cites W1979634285 @default.
• W2115944392 cites W1998614770 @default.
• W2115944392 cites W2000258452 @default.
• W2115944392 cites W2000499358 @default.
• W2115944392 cites W2000905528 @default.
• W2115944392 cites W2016222018 @default.
• W2115944392 cites W2026206736 @default.
• W2115944392 cites W2026879340 @default.
• W2115944392 cites W2052419530 @default.
• W2115944392 cites W2058597871 @default.
• W2115944392 cites W2062273929 @default.
• W2115944392 cites W2062389480 @default.
• W2115944392 cites W2065654211 @default.
• W2115944392 cites W2066949987 @default.
• W2115944392 cites W2067475695 @default.
• W2115944392 cites W2075563193 @default.
• W2115944392 cites W2081249375 @default.
• W2115944392 cites W2094411506 @default.
• W2115944392 cites W2096857883 @default.
• W2115944392 cites W2103093482 @default.
• W2115944392 cites W2103981534 @default.
• W2115944392 cites W2110273274 @default.
• W2115944392 cites W2110906204 @default.
• W2115944392 cites W2113044359 @default.
• W2115944392 cites W2115060813 @default.
• W2115944392 cites W2119198856 @default.
• W2115944392 cites W2129049321 @default.
• W2115944392 cites W2130791906 @default.
• W2115944392 cites W2138561622 @default.
• W2115944392 cites W2145922680 @default.
• W2115944392 cites W2156811085 @default.
• W2115944392 cites W2161740810 @default.
• W2115944392 cites W2168446834 @default.
• W2115944392 doi "https://doi.org/10.1186/1475-2840-13-60" @default.
• W2115944392 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3995632" @default.
• W2115944392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24624928" @default.
• W2115944392 hasPublicationYear "2014" @default.
• W2115944392 type Work @default.
• W2115944392 sameAs 2115944392 @default.
• W2115944392 citedByCount "48" @default.
• W2115944392 countsByYear W21159443922014 @default.
• W2115944392 countsByYear W21159443922015 @default.
• W2115944392 countsByYear W21159443922016 @default.
• W2115944392 countsByYear W21159443922017 @default.
• W2115944392 countsByYear W21159443922018 @default.
• W2115944392 countsByYear W21159443922019 @default.
• W2115944392 countsByYear W21159443922020 @default.
• W2115944392 countsByYear W21159443922021 @default.
• W2115944392 countsByYear W21159443922022 @default.
• W2115944392 countsByYear W21159443922023 @default.
• W2115944392 crossrefType "journal-article" @default.
• W2115944392 hasAuthorship W2115944392A5017854204 @default.
• W2115944392 hasAuthorship W2115944392A5029975728 @default.
• W2115944392 hasAuthorship W2115944392A5030113532 @default.
• W2115944392 hasAuthorship W2115944392A5042961127 @default.
• W2115944392 hasAuthorship W2115944392A5086054133 @default.
• W2115944392 hasBestOaLocation W21159443921 @default.
• W2115944392 hasConcept C126322002 @default.
• W2115944392 hasConcept C134018914 @default.
• W2115944392 hasConcept C147990577 @default.
• W2115944392 hasConcept C169760540 @default.
• W2115944392 hasConcept C170493617 @default.
• W2115944392 hasConcept C185592680 @default.
• W2115944392 hasConcept C2776914184 @default.
• W2115944392 hasConcept C2777292125 @default.
• W2115944392 hasConcept C2778857457 @default.
• W2115944392 hasConcept C71924100 @default.
• W2115944392 hasConcept C86803240 @default.
• W2115944392 hasConcept C89560881 @default.
• W2115944392 hasConcept C98274493 @default.
• W2115944392 hasConceptScore W2115944392C126322002 @default.
• W2115944392 hasConceptScore W2115944392C134018914 @default.
• W2115944392 hasConceptScore W2115944392C147990577 @default.
• W2115944392 hasConceptScore W2115944392C169760540 @default.
• W2115944392 hasConceptScore W2115944392C170493617 @default.
• W2115944392 hasConceptScore W2115944392C185592680 @default.
• W2115944392 hasConceptScore W2115944392C2776914184 @default.
• W2115944392 hasConceptScore W2115944392C2777292125 @default.
• W2115944392 hasConceptScore W2115944392C2778857457 @default.
• W2115944392 hasConceptScore W2115944392C71924100 @default.
• W2115944392 hasConceptScore W2115944392C86803240 @default.
• W2115944392 hasConceptScore W2115944392C89560881 @default.
• W2115944392 hasConceptScore W2115944392C98274493 @default.
• W2115944392 hasIssue "1" @default.
• W2115944392 hasLocation W21159443921 @default.
• W2115944392 hasLocation W21159443922 @default.

• next